CLBT
Cellebrite DI
11.20$
+1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.7% | 47.1% | 11.2% | 15.2% | 39.0% | 60.5% | 19.4% | 28.8% | 26.4% | 63.8% | 15.5% | 13.4% | 29.7% | |
| 2.8% | 2.8% | 3.0% | 2.7% | 2.5% | 2.5% | 2.4% | 2.3% | 2.1% | 3.1% | 5.5% | 6.8% | 4.4% | |
| 5.8% | 5.4% | 6.4% | 6.8% | 8.5% | 8.5% | 8.2% | 7.8% | 12.1% | 9.3% | 11.2% | 11.6% | 11.1% | |
| 17.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.8% | 23.0% | -5.4% | -5.3% | 10.9% | 36.9% | -4.3% | 5.8% | -2.1% | 33.2% | -6.8% | -8.4% | 4.0% | |
| 1.3% | 5.3% | 2.4% | 2.5% | 1.7% | 4.0% | 2.2% | 3.2% | 2.6% | 3.1% | 2.4% | 2.3% | 2.6% | |
| -12.9% | 3.4% | -91.1% | -34.8% | -17.5% | -14.6% | -117.6% | 35.8% | 50.6% | -191.0% | -10.6% | -10.5% | -40.8% | |
| – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 10.5% | 4.9% | 5.7% | 3.5% | 5.2% | 6.2% | 3.4% | 12.2% | 4.2% | 5.4% | 2.7% | 2.8% | 3.8% | |
| 31.6% | 56.4% | -74.9% | -16.2% | 27.5% | 50.7% | -94.1% | 78.3% | 81.0% | -121.8% | 7.2% | 5.8% | -7.4% | |
| 33.4% | 41.8% | 8.8% | 12.7% | 37.3% | 56.5% | 17.2% | 25.6% | 23.8% | 60.8% | 13.1% | 11.1% | 27.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.